Differential patterns of lysosomal dysfunction are seen in the clinicopathological forms of primary progressive aphasia.
Imogen J SwiftSimon SjödinJohan GobomAnn BrinkmalmKaj BlennowHenrik ZetterbergJonathan D RohrerAitana Sogorb-EstevePublished in: Journal of neurology (2023)
Increasing evidence implicates endo-lysosomal dysfunction in frontotemporal dementia (FTD). 18 proteins were quantified using a mass spectrometry assay panel in the cerebrospinal fluid of 36 people with the language variant of FTD, primary progressive aphasia (PPA) (including 13 with non-fluent variant (nfvPPA), 11 with semantic variant (svPPA), and 12 with logopenic variant (lvPPA)) and 19 healthy controls. The concentrations of the cathepsins (B, D, F, L1, and Z) as well as AP-2 complex subunit beta, ganglioside GM2 activator, beta-hexosaminidase subunit beta, tissue alpha L-fucosidase, and ubiquitin were decreased in nfvPPA compared with controls. In contrast, the concentrations of amyloid beta A4 protein, cathepsin Z, and dipeptidyl peptidase 2 were decreased in svPPA compared with controls. No proteins were abnormal in lvPPA. These results indicate a differential alteration of lysosomal proteins in the PPA variants, suggesting those with non-Alzheimer's pathologies are more likely to show abnormal lysosomal function.
Keyphrases
- mass spectrometry
- cerebrospinal fluid
- multiple sclerosis
- oxidative stress
- transcription factor
- autism spectrum disorder
- magnetic resonance
- high resolution
- gene expression
- small molecule
- magnetic resonance imaging
- liquid chromatography
- dna methylation
- protein kinase
- immune response
- computed tomography
- cognitive decline
- capillary electrophoresis
- protein protein
- toll like receptor
- high performance liquid chromatography
- single cell
- solid phase extraction